Gujarat-based Medicap Healthcare files DRHP with SEBI to increase RS 240 Crore

Medicap Healthcare Limited has submitted its Concept Red Herring Prospectus (DRHP) to Market Regulator Securities and Exchange Board of India (SEBI) to launch its initial public offer (IPO). The company plans to increase RS 240 Crore by the issue of Fresh Equity without offer (OFS) component according to its draft documents.

About the company

Medicap HealthCare is a prominent player in the Indian pharmaceutical packaging sector, specialized in the production of pharmaceutical closures, including caps for the head of the euro and the pre -forms of the bottle. The company works from a production facility of 6,732 square meters, located in the Manjusar of Vadodara. The total annual installed production capacity of approximately 751 million units – 389 million units in pharmaceutical gasket euro caps, 149 million units in bottle for forms and 213 million units in other protective caps. The company produced 454 million units in FY2025.

From FY25, the company had a Pan-India presence in 21 states and 5 trade union areas, while the sale of sale is in 14 countries, the DRHP claimed.

The company’s promoters are Kamalkumar Aggarwal, Rajveer Kamal Aggarwal and Minal Aggarwal.

Medicap Healthcare Financials

From FY2025, the turnover of 80.02% came from the activities of the company from the domestic turnover and the balance that was 19.98% from exports to 14 countries. The company has approximately 1.4% of the worldwide market share and more than 40% domestic market share for euro head caps, the DRHP said, referring to F&S report.

Medicap Healthcare IPO will continue

The company established in Gujarat is planning to buy factory and machines for its existing production unit, up to RS 74.37 Crore). Up to RS 32.90 CRORE from the IPO yields is expected to be used for reimbursement or pre-payment of certain loans used by the company.

In addition, the company will make investments in its subsidiary KASR Healthcare Private Limited for reimbursement or pre -payment of loans for an amount of RS 52.80 CRORE). The balance will be used for general business purposes.

Medicap Healthcare IPO Lead Managers

Aryaman Financial Services Limited is the only book Running Lead Manager (BRLM) for the issue. Also read: NSB BPO Solutions IPO: GMP, price band under important details to know before subscription

(Disclaimer: recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)